Tetravalent CD47-antibody constant region fusion protein for use in therapy

Details for Australian Patent Application No. 2010334974 (hide)

Owner Novartis AG

Inventors Huber, Thomas; Kolbinger, Frank; Sarfati, Marie; Welzenbach, Karl

Agent Davies Collison Cave

Pub. Number AU-A-2010334974

PCT Pub. Number WO2011/076781

Priority 61/289,007 22.12.09 US

Filing date 21 December 2010

Wipo publication date 30 June 2011

International Classifications

C07K 14/705 Peptides having more than 20 amino acids

A61K 39/00 Medicinal preparations containing antigens or antibodies

A61P 11/06 Drugs for disorders of the respiratory system

A61P 29/00 Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

C07K 16/00 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 19/00 Hybrid peptides

A61K 38/00 Medicinal preparations containing peptides

Event Publications

12 July 2012 PCT application entered the National Phase

  PCT publication WO2011/076781 Priority application(s): WO2011/076781

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010334979-Accumulator tank with partition walls

2010334970-Rotor having a short circuit cage